Left bundle branch area pacing versus conventional right‑ventricular pacing after TAVI for atrioventricular block
Official title: Prospective Multicenter Randomized Controlled Trial Evaluating the Benefit of Left Bundle Branch Area Stimulation Compared With Conventional Pacing in Post-TAVI Atrioventricular Atrioventricular Block
Run by Nantes University Hospital · NCT07236489 · Data updated 2026-11-12
This will test whether left bundle branch area pacing works better than standard right‑ventricular pacing for people who need a pacemaker after TAVI.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 266 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 7 sites (Brest, Finistère and 6 other locations) |
| Status | Recruiting |
| Started | November 25, 2025 |
| Main results expected | November 2029 |
| Study ends | November 2029 |
| Registry record updated | April 15, 2026 |
| Trial ID | NCT07236489 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients within three months of TAVI who have preserved LVEF (≥50%) and a guideline indication for pacemaker implantation such as third‑degree AV block, Mobitz II or symptomatic Mobitz I block, alternating bundle branch block, HV interval ≥70 ms, or new/worsening conduction disturbances after TAVI.
✕Probably not a fit
Patients with LVEF below 50% before TAVI, those with a prior pacemaker, or those with contraindications to endocardial pacemaker implantation are unlikely to benefit from this comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study enrolls patients who develop atrioventricular block within three months after transcatheter aortic valve implantation and have preserved left ventricular ejection fraction. Participants meeting guideline indications for pacemaker implantation will receive either left bundle branch area pacing or conventional right‑ventricular pacemaker implantation at participating centers. Clinical and echocardiographic outcomes such as changes in LVEF, heart failure hospitalizations, and mortality will be compared during follow‑up. The intent is to see if physiological conduction via left bundle branch area pacing reduces pacing‑induced dyssynchrony and downstream complications compared with standard pacing.
Why it matters
Potential benefit: If successful, this approach could better preserve normal ventricular activation, reduce heart failure events, and help maintain left ventricular function in patients needing pacemakers after TAVI.
How similar studies have gone: Retrospective and observational studies have suggested clinical and physiological benefits of left bundle branch area pacing, but prospective randomized evidence is limited or lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who have undergone TAVI for severe aortic valve disease within the past 3 months * Preserved left ventricular ejection fraction (LVEF ≥ 50%) * Indications for pacemaker implantation according to guidelines, including : * Third-degree atrioventricular (AV) block * Second-degree AV block Mobitz type 2 or symptomatic Mobitz type 1 * Alternating left and right bundle branch block * HV interval ≥ 70 ms during electrophysiological study * Pre-existing right bundle branch block with worsening conduction disturbances post-TAVI * Prolongation of QRS and PR intervals post-procedure justifying pacemaker implantation * Signed informed consent * Patient affiliated with the national health insurance system Exclusion Criteria: * Left ventricular ejection fraction (LVEF) \< 50% before TAVI * Contraindication to implantation of an endocardial pacemaker (vascular access issues, sepsis) * Previously implanted pacemaker * Patients under legal guardianship, curatorship, or judicial protection * Participation in another interventional therapeutic clinical trial
Where it's running
-
Brest University Hospital
Brest, Finistère, France Recruiting -
Rennes University Hospital
Rennes, Ille-et-Vilaine, France Recruiting -
Tours University Hospital
Tours, Indre-et-Loire, France Recruiting -
Nantes University Hospital
Nantes, Loire-Atlantique, France Recruiting -
Rouen University Hospital
Rouen, Seine-Maritime, France Recruiting -
Poitiers University Hospital
Poitiers, Vienne, France Recruiting
Show 1 more location
-
Clermont Ferrand University Hospital
Clermont-Ferrand, Puy-de-Dôme, France Not yet recruiting
Study contacts
- Study coordinator: Research and Innovation Departement of Nantes UH
- Email: bp-prom-regl@chu-nantes.fr
- Phone: +33253482810
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transjugular implantation of a leadless pacemaker (Aveir VR) for ventricular pacing
This study tests whether placing an Aveir VR leadless pacemaker through the neck vein can safely provide ventricular pacing in adults with bradycardia.
-
3D Echocardiography to See How CIEDs May Worsen Tricuspid Regurgitation
This study tests whether different CIEDs (leadless pacemakers, LBBaP, and conventional pacemakers) differ in causing worsening tricuspid regurgitation, using 3D heart imaging.
-
Focal Cryoablation vs. Radiofrequency Cardioneuroablation for Bradyarrhythmias
This study tests whether focal cryoablation can treat vagally driven slow heart rhythms as well as traditional radiofrequency ablation in adults with bradycardia or related syncope.
-
Left bundle area pacing with Closed Loop Stimulation in dual‑chamber pacemakers
This study tests whether a dual‑chamber pacemaker using left bundle area pacing and Closed Loop Stimulation can reduce device‑detected atrial fibrillation over 24 months in patients with sinus node disease and AV conduction issues.
-
Higher pacemaker rate for people with cardiac amyloidosis
This study will see if temporarily increasing the pacemaker rate improves heart-failure symptoms and exercise tolerance in adults with cardiac amyloidosis who already have pacemakers.
-
Remote ECG monitoring after TAVI
This compares continuous 30-day remote ECG monitoring to standard short-term monitoring for adults after TAVI to see if it detects rhythm problems earlier.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.